Phoenix’s Advanced Cancer Screening uses a new method of MRI scanning known as Whole Body-Diffusion Weighted Imaging, a non-invasive technique developed following years of clinical research with the aim of diagnosing cancer much earlier in apparently healthy people.

In just 45 mins, the machine can diagnose asymptomatic tumours and scan areas which are not normally screened such as the bladder, kidney, non-Hodgkin lymphoma, as well as the liver and pancreas.  

Advanced cancer screening detects early tumours 

“We are delighted to introduce our new Advanced Cancer Screening, which is focused on detecting asymptomatic tumours in clients as early as possible, which as we all know is so important when it comes to giving diagnosed patients the best chance they can have for successful treatment,” Prof Anwar Padhani said. “We know that early diagnosis is key to tackling this challenge, and we are pleased to offer clients a new way to access this.”

Early diagnosis frequently means shorter courses of less intensive treatment, which is far better for the patient, and also saves money for payers, whether individuals or insurers. All MRI scans work by mapping the body using magnetic fields, but this particular process doesn’t involve any radiation used in CT scans or x-rays. This eliminates unnecessary radiation exposure, which can increase the risk of developing cancer in later life.  

Healthcare experts have been testing the new process and a recent private patient, said: “Like many people, the pandemic has made me more conscious of my health. I have a history of cancer in my family, and I was keen to have a thorough check over.  

“My doctor told me about the Advanced Cancer Screening programme, so I booked myself an appointment. The scan lasted 45 minutes and the whole process was easy. I didn’t have to fast, didn’t need any injections, and I could head off home straight afterwards with no side effects.” 

Data conducted by Cancer Research UK last year revealed that a worrying number of people in the public health sector are not getting access to the cancer treatment that they need due to coronavirus restrictions. The pressure on public health services could serve as a boost, however, to private hospital groups around the world as patients seek treatment elsewhere that they are unable to access in their home country.